COSMOS Pharmaceutical Corporation
3349.T · JPX
8/31/2025 | 5/31/2025 | 2/28/2025 | 11/30/2024 | |
|---|---|---|---|---|
| Market Cap | ¥699 | ¥700 | ¥558 | ¥585 |
| - Cash | ¥50 | ¥57 | ¥23 | ¥39 |
| + Debt | ¥42 | ¥50 | ¥29 | ¥26 |
| Enterprise Value | ¥691 | ¥693 | ¥564 | ¥572 |
| Revenue | ¥272 | ¥259 | ¥246 | ¥244 |
| % Growth | 5.1% | 5.2% | 0.9% | – |
| Gross Profit | ¥57 | ¥54 | ¥53 | ¥52 |
| % Margin | 21% | 20.9% | 21.6% | 21.1% |
| EBITDA | ¥18 | ¥15 | ¥17 | ¥14 |
| % Margin | 6.6% | 5.9% | 7.1% | 5.8% |
| Net Income | ¥8 | ¥9 | ¥8 | ¥6 |
| % Margin | 3% | 3.3% | 3.2% | 2.6% |
| EPS Diluted | 103.09 | 108.95 | 99.86 | 79.3 |
| % Growth | -5.4% | 9.1% | 25.9% | – |
| Operating Cash Flow | – | ¥0 | ¥0 | ¥0 |
| Capital Expenditures | – | ¥0 | ¥0 | ¥0 |
| Free Cash Flow | – | ¥0 | ¥0 | ¥0 |